VivoSeq
Cardiovascular

Chronic Stable Angina

0

Pipeline Programs↗

0

Active Trials↗

6

Companies Involved↗

Chronic Stable Angina is an early-stage landscape with 0 programs across 6 companies. The most active players are Sinphar Pharmaceutical Co., Ltd, Takeda, Tasly Pharmaceuticals, Inc..

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

21/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

Sinphar Pharmaceutical Co., Ltd

0 programs

PreclinicalTakeda logo

Takeda

0 programs

PreclinicalT

Tasly Pharmaceuticals, Inc.

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalS

Shaanxi Buchang Pharmaceutical Co., Ltd

0 programs

PreclinicalP

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

14

clinical trials

Completed9 · 64%
Terminated2 · 14%
Unknown status2 · 14%
Withdrawn1 · 7%

Clinical Trials

Trial Activity

14 trials

Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina
Completed·TTasly Pharmaceuticals, Inc.·Phase 2·NCT00797953·124 enrolled
Danhong Injection in the Treatment of Chronic Stable Angina
Completed·CChina Academy of Chinese Medical Sciences·Phase 4·NCT01681316·920 enrolled
Efficacy and Safety of Lacidipine in Chronic Stable Angina
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 2·NCT02232607·283 enrolled
Phase II Study of STA-2 in Patients With Chronic Stable Angina
Completed·SSinphar Pharmaceutical Co., Ltd·Phase 2·NCT01484912·79 enrolled
Phase IIb Study of STA-2 in Patients With Chronic Stable Angina
Completed·SSinphar Pharmaceutical Co., Ltd·Phase 2·NCT01239511·186 enrolled
Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00143195·200 enrolled
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
Completed·NNorth Florida Foundation for Research and Education·Phase 2·NCT02265796·50 enrolled
Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina
Completed·SSheffield Teaching Hospitals NHS Foundation Trust·Phase 4·NCT00131183·15 enrolled
Acute Episodes in Chronic Stable Angina: Assessment of the Use of the Coronary Vasodilator Propatyl Nitrate.
Completed·FFundação Educacional Serra dos Órgãos·Phase 4·NCT02315976·200 enrolled
Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina
Terminated·Takeda logoTakeda·Phase 2·NCT01549977·1 enrolled
Rosiglitazone Versus Placebo in Chronic Stable Angina
Terminated·UUniversity of Glasgow·Phase 4·NCT00225355·80 enrolled
Gene Therapy for the Treatment of Chronic Stable Angina
Withdrawn·HHelixmith Co., Ltd.·Phase 1/2·NCT01002495
Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.
Unknown status·FFerozsons Laboratories Ltd.·Phase 4·NCT01397994·40 enrolled
Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina
Unknown status·SShaanxi Buchang Pharmaceutical Co., Ltd·Phase 4·NCT02280850·300 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)